23.03.2016 • News

Bain Capital Exits IMCD

US private equity firm Bain Capital has sold its remaining 7.9% stake in Netherlands-based specialty chemicals distributor IMCD.

Bain placed 4.2 million shares, priced at €31.25 per share, with institutional investors. The transaction was led by Goldman Sachs International and Deutsche Bank.

Bain used to be IMCD’s main shareholder before the distributor launched an initial public offering (IPO) on the Amsterdam Euronext stock exchange in June 2014. Bain had already reduced its interest from 39.17% to 7.9% by the end of last year.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.